BGI华大基因品牌怎么样 申请店铺

华大基因成立于1999年，以“产学研”一体化的创新发展模式引领基因组学的发展，已成为全球最大的基因组学研发机构，在全球设立分支机构并建立广泛的合作，将前沿的多组学科研成果应用于医学健康、农业育种、资源保存等领域，推动基因科技成果转化。

华大基因以其独特的创新教育和人才培养模式带动生命科学领域综合素质人才的发展，并与南方科技大学、哥本哈根大学合作共建特色学院。华大基因还负责组建我国第一个国家级综合基因库——国家基因库，将更有效地保护、开发和利用中国宝贵的遗传资源，维护国家生物信息安全，提升中国在生物技术领域的战略制高点。

2013年3月，华大基因成功完成对美国上市公司CompleteGenomics的收购，实现了基因测序上下游产业链的闭环，为生物行业的长远发展奠定了坚实基础。

华大基因创新发展成为现代企业发展的典范，2013年，华大基因名列FastCompany“2013年中国十大最具创新力企业”第二、入选麻省理工《科技创业》杂志“2013年全球最具创新力技术企业”50强、入选《环球科学》“2013年度最具影响力十大研发中心”、荣获2014世界技术奖生物技术类（企业）奖。

华大基因将基础研究、产业应用和教育实践并行发展，遵循“科技合作”、“科技服务”、“医学服务”、“人人服务”的发展轨迹，实现基因科技造福人类的梦想！

全球分布|科研实力|平台实力|未来展望

经过十五年的发展，华大基因足迹遍布全球。截至2013年11月，已覆盖中国（内地、香港、澳门、台湾）、美洲（美国、加拿大、巴西、墨西哥、阿根廷、智利等）、欧洲（荷兰、英国、丹麦、法国、意大利、瑞典、比利时、西班牙、爱尔兰、土耳其、挪威、葡萄牙、芬兰、奥地利、瑞士、波兰、南非、斯洛文尼亚、希腊、罗马尼亚、俄罗斯、捷克、斯洛伐克、爱沙尼亚、埃及、塞浦路斯、匈牙利、保加利亚、肯尼亚等）、亚太（日本、新加坡、马来西亚、菲律宾、泰国、越南、印度尼西亚、澳大利亚、新西兰、印度、孟加拉、斯里兰卡、巴基斯坦、阿联酋、卡塔尔、科威特、沙特阿拉伯、伊拉克等）等多个国家和地区。

Founded in 1999, Huada gene has become the world's largest genomics research and development organization, leading the development of genomics with the innovative development mode of integration of production, learning and research. It has set up branches and established extensive cooperation in the world, and applied the cutting-edge research results of multi group science to medical health, agricultural breeding, resource conservation and other fields, so as to promote the transformation of gene science and technology achievements. With its unique innovative education and talent training mode, BGI has driven the development of comprehensive quality talents in the field of life science, and has cooperated with Southern University of science and technology and Copenhagen University to build a characteristic college. BGI is also responsible for the establishment of China's first national comprehensive gene pool, the national gene pool, which will more effectively protect, develop and utilize China's precious genetic resources, maintain the National Bio information security, and enhance China's strategic commanding point in the field of biotechnology. In March 2013, BGI successfully completed the acquisition of completegenomics, a US listed company, and realized the closed-loop of upstream and downstream industrial chains of gene sequencing, laying a solid foundation for the long-term development of the biological industry. BGI's innovation and development has become a model for the development of modern enterprises. In 2013, BGI ranked second in fastcompany's "top 10 most innovative enterprises in China in 2013". It was selected into the top 50 most innovative technology enterprises in the world in 2013 by MIT science and technology entrepreneurship magazine, the top 10 most influential R & D centers in 2013 by global science, and the world technology 2014 Biotechnology (enterprise) award. BGI will develop basic research, industrial application and educational practice in parallel, follow the development track of "scientific and technological cooperation", "scientific and technological service", "medical service" and "everyone's service", and realize the dream of gene technology benefiting mankind! Global distribution | scientific research strength | platform strength | future outlook after 15 years of development, BGI's gene footprint is all over the world. As of November 2013, it has covered China (mainland, Hong Kong, Macao, Taiwan), America (US, Canada, Brazil, Mexico, Argentina, Chile, etc.), Europe (Netherlands, UK, Denmark, France, Italy, Sweden, Belgium, Spain, Ireland, Turkey, Norway, Portugal, Finland, Austria, Switzerland, Poland, South Africa, slovens, etc.) Nigeria, Greece, Romania, Russia, Czech Republic, Slovakia, Estonia, Egypt, Cyprus, Hungary, Bulgaria, Kenya, etc.), Asia Pacific (Japan, Singapore, Malaysia, Philippines, Thailand, Vietnam, Indonesia, Australia, New Zealand, India, Bangladesh, Sri Lanka, Pakistan, UAE, Qatar Kuwait, Saudi Arabia, Iraq, etc.).

本文链接： https://brand.waitui.com/b56e60897.html 联系电话：075533023888